
News|Articles|April 1, 2003
New agent reduces PTH levels in hemodialysis patients with secondary hyperparathyroidism
New agent reduces PTH levels in hemodialysis patients with secondary hyperparathyroidism.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
3
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
4
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
5


























